CLINICAL_TRIALS
trial_result
· 2010-10-18
Clinical Trial Update: MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066) [Phase 3]
Summary
Phase 3 trial comparing MK0431A to pioglitazone in adults with Type 2 diabetes mellitus has completed. Results were posted in October 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2010-10-18